Drug Profile
Bevacizumab biosimilar - AskGene Pharma
Alternative Names: ASK B1202Latest Information Update: 12 Jan 2022
Price :
$50
*
At a glance
- Originator AskGene Pharma
- Developer AskGene Pharma; Jiangsu Aosaikang Pharmaceutical
- Class Antineoplastics; Eye disorder therapies; Immunotherapies; Monoclonal antibodies
- Mechanism of Action Angiogenesis inhibitors; Vascular endothelial growth factor A inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase III Cancer